CellChorus
The dynamic single-cell analysis company
What they do
Cell therapy and immunotherapy developers struggle to efficiently and accurately analyze immune cell behavior over time from large volumes of microscopy data, slowing R&D and manufacturing decisions.
An AI-powered platform that analyzes thousands of time-lapse microscopy videos in parallel to quantify single-cell movement, interactions, and function over time.
Biopharma companies and biotech startups developing cell therapies, antibody therapeutics, and vaccines.
Founders
Daniel Meyer is the CEO of CellChorus, the leader in providing dynamic single-cell functional analysis to the life sciences industry. Dan was the Chief Operating Officer and a board member of Genospace until its acquisition by HCA Healthcare (NYSE:HCA). He was a member of the venture capital investment teams at Arboretum Ventures and PJC.vc. Dan holds a B.A. in mathematics and economics from Middlebury College and an M.B.A. from the Tuck School of Business at Dartmouth.
Company timeline
- Founded2020
- YC batchSummer 2021
- StatusActive
- Team size4 people
- LocationHouston, TX, USA
Similar startups
